Clinical Trial Update: DatScan With Prototype Collimator

View source ↗

Summary

A completed clinical trial evaluating DatScan (ioflupane I-123) with a prototype collimator for Parkinson disease imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• DaTscan (ioflupane)

Snippet

Sponsor: University of Minnesota | Conditions: Parkinson Disease | Status: COMPLETED